Deciphering the role of phosphatidylinositol 3-kinase mutations in human epidermal growth factor receptor 2-positive breast cancer

J Clin Oncol. 2015 Apr 20;33(12):1407-9. doi: 10.1200/JCO.2014.60.0742. Epub 2015 Mar 23.

Authors

Shom Goel¹, Ian E Krop²

Affiliations

¹ Dana-Farber Cancer Institute, Boston, MA.
² Dana-Farber Cancer Institute, Boston, MA ikrop@partners.org.

PMID: 25800754
DOI: 10.1200/JCO.2014.60.0742

No abstract available

Publication types

Comment

MeSH terms

Antibodies, Monoclonal, Humanized / administration & dosage*
Breast Neoplasms / drug therapy*
Breast Neoplasms / genetics*
Female
Humans
Mutation*
Phosphatidylinositol 3-Kinases / genetics*

Substances

Antibodies, Monoclonal, Humanized
Phosphatidylinositol 3-Kinases